These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39323741)

  • 1. Bone-targeting engineered milk-derived extracellular vesicles for MRI-assisted therapy of osteoporosis.
    Huang Q; Jiang Y; Cao Y; Ding Y; Cai J; Yang T; Zhou X; Wu Q; Li D; Liu Q; Li F
    Regen Biomater; 2024; 11():rbae112. PubMed ID: 39323741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Milk-Derived Extracellular Vesicles Inhibit Osteoclastogenesis and Ameliorate Bone Loss in Ovariectomized Mice by Improving Gut Microbiota.
    Hao H; Liu Q; Zheng T; Li J; Zhang T; Yao Y; Liu Y; Lin K; Liu T; Gong P; Zhang Z; Yi H
    J Agric Food Chem; 2024 Mar; 72(9):4726-4736. PubMed ID: 38294408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-Targeting Peptide and RNF146 Modified Apoptotic Extracellular Vesicles Alleviate Osteoporosis.
    Gui L; Ye Q; Yu L; Dou G; Zhou Y; Liu Y; Zhang Y; Yang X; Jin F; Liu S; Jin Y; Ren L
    Int J Nanomedicine; 2024; 19():471-488. PubMed ID: 38250192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Effect of Bovine Milk Extracellular Vesicles on Alveolar Bone Loss.
    Silva FRF; Heredia JE; Duffles LF; Arntz OJ; Teixeira MM; Ferreira AVM; Silva TA; van de Loo FAJ; Macari S; Oliveira MC
    Mol Nutr Food Res; 2024 Feb; 68(3):e2300445. PubMed ID: 38087782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine Milk Extracellular Vesicles Are Osteoprotective by Increasing Osteocyte Numbers and Targeting RANKL/OPG System in Experimental Models of Bone Loss.
    Oliveira MC; Pieters BCH; Guimarães PB; Duffles LF; Heredia JE; Silveira ALM; Oliveira ACC; Teixeira MM; Ferreira AVM; Silva TA; van de Loo FAJ; Macari S
    Front Bioeng Biotechnol; 2020; 8():891. PubMed ID: 32850743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant-Engineered Milk-Derived Extracellular Vesicles for Accelerating Wound Healing via Regulation of the PI3K-AKT Signaling Pathway.
    Fan L; Ma X; Liu B; Yang Y; Yang Y; Ren T; Li Y
    Adv Healthc Mater; 2023 Dec; 12(32):e2301865. PubMed ID: 37660257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversing the imbalance in bone homeostasis via sustained release of SIRT-1 agonist to promote bone healing under osteoporotic condition.
    Zhang W; Zhou X; Hou W; Chen E; Ye C; Chen M; Lu Q; Yu X; Li W
    Bioact Mater; 2023 Jan; 19():429-443. PubMed ID: 35574058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
    Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
    J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese Herbal Medicine Guilu Erxian Glue Inhibits Osteoclast Formation and Activity via Mc3t3-Derived Extracellular Vesicles in vitro.
    Si Y; Li S; Guo Y; Wang L; Ma Y; Yin H
    Altern Ther Health Med; 2023 Sep; 29(6):400-407. PubMed ID: 37384403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice.
    Yang K; Miron RJ; Bian Z; Zhang YF
    Bone; 2018 Sep; 114():40-49. PubMed ID: 29883786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered Plant Virus Complexes with a RANK Motif Modulator and Bone Targeting for Osteoporosis Treatment.
    Li Y; Cao S; Li Q; Li H; Yu L; Shao B; Yuan Q; Zou S; Zhou C
    ACS Appl Mater Interfaces; 2023 Mar; 15(9):11485-11495. PubMed ID: 36821292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine milk extracellular vesicles induce the proliferation and differentiation of osteoblasts and promote osteogenesis in rats.
    Go G; Jeon J; Lee G; Lee JH; Lee SH
    J Food Biochem; 2021 Apr; 45(4):e13705. PubMed ID: 33748986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption.
    Yang YT; Meng JH; Hu B; Ma CY; Zhao CC; Teng WS; Hong JQ; Li SH; Jiang GY; Wang C; Zhou CH; Yan SG
    Life Sci; 2018 Sep; 209():409-419. PubMed ID: 30096387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis.
    Ran B; Ren X; Lin X; Teng Y; Xin F; Ma W; Zhao X; Li M; Wang J; Wang C; Sun L; Zhang J
    J Control Release; 2024 Jun; 370():811-820. PubMed ID: 38754632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual regulation of osteoclastogenesis and osteogenesis for osteoporosis therapy by iron oxide hydroxyapatite core/shell nanocomposites.
    Li M; Fu S; Cai Z; Li D; Liu L; Deng D; Jin R; Ai H
    Regen Biomater; 2021 Oct; 8(5):rbab027. PubMed ID: 34434563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.
    Liu L; Jin R; Duan J; Yang L; Cai Z; Zhu W; Nie Y; He J; Xia C; Gong Q; Song B; Anderson JM; Ai H
    Acta Biomater; 2020 Feb; 103():281-292. PubMed ID: 31866569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-derived extracellular vesicles improve disuse-induced osteoporosis by rebalancing bone formation and bone resorption.
    Huang H; Ma S; Xing X; Su X; Xu X; Tang Q; Gao X; Yang J; Li M; Liang C; Wu Y; Liao L; Tian W
    Acta Biomater; 2023 Feb; 157():609-624. PubMed ID: 36526242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism.
    Hu Y; Zhang Y; Ni CY; Chen CY; Rao SS; Yin H; Huang J; Tan YJ; Wang ZX; Cao J; Liu ZZ; Xie PL; Wu B; Luo J; Xie H
    Theranostics; 2020; 10(5):2293-2308. PubMed ID: 32089743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating osteoclasts with nanoparticles: A path for osteoporosis management?
    Rouco H; García-García P; Briffault E; Diaz-Rodriguez P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1885. PubMed ID: 37037204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.
    Yang T; Chen W; Gan K; Wang C; Xie X; Su Y; Lian H; Xu J; Zhao J; Liu Q
    J Transl Med; 2023 Nov; 21(1):839. PubMed ID: 37993937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.